Holocene Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
50,370
+18,894
| +60% | +$984K | 0.01% | 518 |
|
|
2025
Q1 | $1.9M | Buy |
+31,476
| New | +$1.9M | 0.01% | 541 |
|
|
2023
Q1 | – | Sell |
-53,053
| Closed | -$4.7M | – | 728 |
|
|
2022
Q4 | $4.7M | Buy |
53,053
+30,991
| +140% | +$2.75M | 0.03% | 292 |
|
|
2022
Q3 | $1.77M | Buy |
+22,062
| New | +$1.77M | 0.01% | 462 |
|
|
2020
Q4 | – | Sell |
-6,922
| Closed | -$545K | – | 739 |
|
|
2020
Q3 | $545K | Buy |
6,922
+3,407
| +97% | +$268K | ﹤0.01% | 545 |
|
|
2020
Q2 | $253K | Sell |
3,515
-2,948
| -46% | -$212K | ﹤0.01% | 559 |
|
|
2020
Q1 | $370K | Buy |
6,463
+2,074
| +47% | +$119K | ﹤0.01% | 583 |
|
|
2019
Q4 | $491K | Sell |
4,389
-817
| -16% | -$91.4K | ﹤0.01% | 614 |
|
|
2019
Q3 | $501K | Sell |
5,206
-3,029
| -37% | -$291K | 0.01% | 581 |
|
|
2019
Q2 | $705K | Sell |
8,235
-1,812
| -18% | -$155K | 0.01% | 364 |
|
|
2019
Q1 | $836K | Sell |
10,047
-2,586
| -20% | -$215K | 0.01% | 282 |
|
|
2018
Q4 | $811K | Buy |
12,633
+5,600
| +80% | +$360K | 0.01% | 297 |
|
|
2018
Q3 | $557K | Buy |
+7,033
| New | +$557K | 0.01% | 498 |
|